Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 280 | 220 | 91 | 410 | 347 |
| Cost of Goods | 121 | 101 | 78 | 147 | 146 |
| Gross Profit | 159 | 119 | 13 | 263 | 201 |
| Operating Expenses | 1,179 | 1,094 | 1,501 | 1,189 | 1,150 |
| Operating Income | -1,020 | -975 | -1,488 | -926 | -949 |
| Interest Expense | 4 | 5 | 5 | 5 | 6 |
| Other Income | 12 | 28 | 21 | 13 | 18 |
| Pre-tax Income | -1,012 | -952 | -1,471 | -918 | -938 |
| Net Income Continuous | -1,012 | -952 | -1,471 | -918 | -938 |
| Net Income | $-1,012 | $-952 | $-1,471 | $-918 | $-938 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-942 | $-886 | $-1,401 | $-844 | $-863 |